Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S. Kario K, et al. Among authors: yoshida t. Circ J. 2017 Jun 23;81(7):948-957. doi: 10.1253/circj.CJ-17-0109. Epub 2017 Mar 17. Circ J. 2017. PMID: 28321001 Free article. Clinical Trial.
Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. Kario K, et al. Among authors: yoshida t. J Clin Hypertens (Greenwich). 2016 Oct;18(10):1036-1044. doi: 10.1111/jch.12814. Epub 2016 Mar 16. J Clin Hypertens (Greenwich). 2016. PMID: 26989846 Free PMC article. Clinical Trial.
Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study.
Kario K, Okada K, Kato M, Nishizawa M, Yoshida T, Asano T, Uchiyama K, Niijima Y, Katsuya T, Urata H, Osuga JI, Fujiwara T, Yamazaki S, Tomitani N, Kanegae H. Kario K, et al. Among authors: yoshida t. Circulation. 2019 Apr 30;139(18):2089-2097. doi: 10.1161/CIRCULATIONAHA.118.037076. Epub 2018 Nov 29. Circulation. 2019. PMID: 30586745 Free PMC article.
Rationale, design, and baseline characteristics of the Cardiovascular Prognostic COUPLING Study in Japan (the COUPLING Registry).
Kario K, Kabutoya T, Fujiwara T, Negishi K, Nishizawa M, Yamamoto M, Yamagiwa K, Kawashima A, Yoshida T, Nakazato J, Matsui Y, Sekizuka H, Abe H, Abe Y, Fujita Y, Sato K, Narita K, Tsuchiya N, Kubota Y, Hashizume T, Hoshide S. Kario K, et al. Among authors: yoshida t. J Clin Hypertens (Greenwich). 2020 Mar;22(3):465-474. doi: 10.1111/jch.13764. Epub 2020 Feb 24. J Clin Hypertens (Greenwich). 2020. PMID: 32092246 Free PMC article.
Age-related difference of the association of cardiovascular risk factors with the cardio-ankle vascular index in the Cardiovascular Prognostic Coupling Study in Japan (the Coupling Registry).
Kabutoya T, Hoshide S, Fujiwara T, Negishi K, Nishizawa M, Yamamoto M, Yamagiwa K, Kawashima A, Yoshida T, Nakazato J, Matsui Y, Sekizuka H, Abe H, Abe Y, Fujita Y, Sato K, Narita K, Tsuchiya N, Kubota Y, Hashizume T, Kario K. Kabutoya T, et al. Among authors: yoshida t. J Clin Hypertens (Greenwich). 2020 Jul;22(7):1208-1215. doi: 10.1111/jch.13896. Epub 2020 Jun 12. J Clin Hypertens (Greenwich). 2020. PMID: 32530542 Free PMC article.
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, Abe H, Katsuya T, Fujita Y, Okazaki O, Yano Y, Tomitani N, Kanegae H; JAMP Study Group. Kario K, et al. Among authors: yoshida t. Circulation. 2020 Nov 10;142(19):1810-1820. doi: 10.1161/CIRCULATIONAHA.120.049730. Epub 2020 Nov 2. Circulation. 2020. PMID: 33131317 Free PMC article. Clinical Trial.
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kojima S, et al. Rheumatology (Oxford). 2022 May 30;61(6):2346-2359. doi: 10.1093/rheumatology/keab739. Rheumatology (Oxford). 2022. PMID: 34605897 Clinical Trial.
11,228 results
You have reached the last available page of results. Please see the User Guide for more information.